Evoke plc (LON:EVOK – Get Free Report) shares traded down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
EVOK has been the topic of a number of research analyst reports. Berenberg Bank cut their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.
Get Our Latest Stock Report on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, sell-side analysts predict that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Buying and Selling at Evoke
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
Evoke Company Profile
Featured Stories
- Five stocks we like better than Evoke
- Bank Stocks – Best Bank Stocks to Invest In
- MarketBeat Week in Review – 03/24 – 03/28
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Invest in Blue Chip Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.